Hill David Louis Insider Trades

Insider Trading History

Track insider trading activity for Hill David Louis. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $2.53k 357 shares
Last Trade
Mar 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.68k 357 shares
$7.50
$7.09
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $17.7k 2,500 shares
Last Trade
Mar 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.2k 2,500 shares
$35.28
$7.09
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $17.7k 2,500 shares
Last Trade
Mar 23, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 2,500 shares
$70.14
$7.09
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $17.7k 2,500 shares
Last Trade
Dec 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$213k 2,500 shares
$85.26
$7.09
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $177k 25,000 shares
Last Trade
Jun 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.5k 25,000 shares
$0.86
$7.09
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $0 0 shares
Last Trade
Sep 01, 2014 Sale
$21.5k 25,000 shares
$0.86
$7.09
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $0 0 shares
Last Trade
Sep 01, 2014 Sale
$21.5k 25,000 shares
$0.86
$7.09
Edesa Biotech
Edesa Biotech EDSA
Director
Holding Value $0 0 shares
Last Trade
Sep 01, 2014 Sale
$21.5k 25,000 shares
$0.86
$7.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up